Global Iron Drugs Market Forecasts to 2022: Prevalence of CKD and Other Diseases Such as CHF is Increasing in Emerging Economies - ResearchAndMarkets.com

DUBLIN--()--The "Global Iron Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Iron Drugs Market is expected to grow at a CAGR of 9.27% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the growing focus on the emerging economies. Several vendors are focusing on emerging economies due to the opportunities for growth. This is because the prevalence of CKD and other diseases such as CHF is increasing in emerging economies such as India, China, and Brazil.

According to the report, one driver influencing this market is the presence of large patient pool with various disorders. The demand for iron drugs is increasing due to the presence of a large patient pool with various disorders. Some risk factors of iron deficiency include CKD, non-dialysis CKD, congestive heart failure (CHF), and postpartum anaemia. The presence of large patient pool with various disorders will drive the growth of the global iron drugs market during the forecast period.

Further, the report states that one challenge affecting this market is the high cost of drugs. The high cost of IV iron drugs is a challenge for the growth of the global iron drugs market. Though IV iron drugs are associated with many advantages over oral iron drugs, they are expensive than oral iron drugs.

Key Vendors

  • Allergan
  • AMAG Pharmaceuticals
  • Daiichi Sankyo
  • PharmaCosmos
  • Vifor Pharma

Key Topics Covered

1. Executive Summary

2. Scope of the Report

3. Research Methodology

4. Market Landscape

5. Market Sizing

6. Five Forces Analysis

7. Market Segmentation by Product

8. Customer Landscape

9. Regional Landscape

10. Decision Framework

11. Drivers and Challenges

12. Market Trends

13. Vendor Landscape

14. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/wf2789/global_iron_drugs?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs